Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)Product type:AdviceProgramme:Evidence summaryPublished date: 2 December 2015
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)Product type:AdviceProgramme:Evidence summaryPublished date: 2 December 2015
Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)Product type:AdviceProgramme:Evidence summaryPublished date: 13 October 2015
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)Product type:AdviceProgramme:Evidence summaryPublished date: 3 July 2015
Type 2 diabetes: dulaglutide (ESNM59)Product type:AdviceProgramme:Evidence summaryPublished date: 16 June 2015
Type 2 diabetes: alogliptin (ESNM20)Product type:AdviceProgramme:Evidence summaryLast updated: 1 October 2014Published date: 21 May 2013
Type 2 diabetes: lixisenatide (ESNM26)Product type:AdviceProgramme:Evidence summaryPublished date: 24 September 2013
Type 1 diabetes: insulin degludec (ESNM24)Product type:AdviceProgramme:Evidence summaryPublished date: 10 September 2013
Type 2 diabetes: insulin degludec (ESNM25)Product type:AdviceProgramme:Evidence summaryPublished date: 10 September 2013